Stock Market News
Physiomics wins major new pharma client
Technology-based cancer treatment solutions provider Physiomics announced on Friday that it has been awarded a contract by an unnamed new major pharmaceutical client.
The AIM-traded company said the project, which was expected to be completed during its current financial year, involves the use of its 'Virtual Tumour' technology in a pre-clinical setting, with a value of approximately £35k.
Physiomics said its Virtual Tumour is a sophisticated computer model that simulates tumour cell division and predicts the effect of different anti-cancer regimes to support pre-clinical and clinical oncology development programs.
It added that Virtual Tumour helps customers to balance efficacy and toxicity, and to prioritise the most effective drug combinations while reducing time and cost.
"We are delighted to be working with a significant new client," said Physiomics CEO Jim Millen.
"If this initial project is successful, we would hope to develop a longer-term relationship."
The AIM-traded company said the project, which was expected to be completed during its current financial year, involves the use of its 'Virtual Tumour' technology in a pre-clinical setting, with a value of approximately £35k.
Physiomics said its Virtual Tumour is a sophisticated computer model that simulates tumour cell division and predicts the effect of different anti-cancer regimes to support pre-clinical and clinical oncology development programs.
It added that Virtual Tumour helps customers to balance efficacy and toxicity, and to prioritise the most effective drug combinations while reducing time and cost.
"We are delighted to be working with a significant new client," said Physiomics CEO Jim Millen.
"If this initial project is successful, we would hope to develop a longer-term relationship."
Related share prices |
---|
Physiomics (PYC) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price